Streetbeat News

Price Targets

DRRX

Cantor Fitzgerald analyst Kristen Kluska has maintained an Overweight rating on Durect (NASDAQ:DRRX) but lowered the price target from $44 to $41.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 2:32 pm

PLRX

RBC Capital analyst Brian Abrahams has maintained an 'Outperform' rating on Pliant Therapeutics (NASDAQ:PLRX), but lowered the price target from $57 to $54.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 2:30 pm

HALO

Morgan Stanley analyst Vikram Purohit maintains an Overweight rating on Halozyme Therapeutics and raises the price target from $60 to $61.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 2:29 pm

JACK

RBC Capital analyst Christopher Carril has reiterated an 'Outperform' rating on Jack In The Box (NASDAQ:JACK), maintaining a price target of $110.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 2:29 pm

TMCI

Stephens & Co. analyst George Sellers maintains an Equal-Weight rating on Treace Medical Concepts (NASDAQ:TMCI) and lowers the price target from $27 to $25.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 2:28 pm

GE

Morgan Stanley analyst Josh Sullivan maintains an Overweight rating on General Electric (NYSE:GE) and raises the price target from $122 to $125.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 2:27 pm

INFA

RBC Capital analyst Matthew Hedberg maintains an Outperform rating on Informatica (NYSE:INFA) and raises the price target from $22 to $24.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 2:26 pm

RBLX

Barclays analyst Mario Lu has maintained an Underweight rating on Roblox (NYSE:RBLX) and lowered the price target from $32 to $26.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 10, 2023 | 2:26 pm

FATE

Morgan Stanley analyst Michael Ulz has maintained an Equal-Weight rating on Fate Therapeutics (NASDAQ:FATE) but lowered the price target from $8 to $5.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 2:25 pm

FANG

RBC Capital analyst Scott Hanold has reiterated his 'Outperform' rating on Diamondback Energy (NASDAQ:FANG), maintaining a price target of $170.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 2:24 pm